Health

Moderna Receives Full U.S. FDA Approval for COVID-19 Vaccine, Spikevax in Children Aged 6 Months Through 11 Years at Increased Risk for COVID-19 Disease

DailyTrendDailyTrend
Jul 12, 2025 - 22:00
 0  0
Moderna Receives Full U.S. FDA Approval for COVID-19 Vaccine, Spikevax in Children Aged 6 Months Through 11 Years at Increased Risk for COVID-19 Disease
CAMBRIDGE, MA / ACCESS Newswire / July 10, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for Spikevax®, the Company's...
Read More

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0
DailyTrend
DailyTrend

Related Posts

Medical Groups Warn Against Visa Fees for Foreign Doctors

Medical Groups Warn Against Visa Fees for Foreign Doctors

DailyTrend Sep 26, 2025  0  0

Fragile N.C. Residents Lose Medicaid Support for Food and Housing

Fragile N.C. Residents Lose Medicaid Support for Food a...

DailyTrend Sep 30, 2025  0  0

Trump May Try to Force Drugmakers to Match European Prices

Trump May Try to Force Drugmakers to Match European Prices

DailyTrend Sep 25, 2025  0  0

FDA Approves Inluriyo (imlunestrant) for Adults with ER...

DailyTrend Sep 25, 2025  0  0

FDA Approves Palsonify (paltusotine) for the Treatment ...

DailyTrend Sep 29, 2025  0  0

Blood and Plasma Warming Device Correction: 3M Company Issues Correction for Ranger Blood/Fluid Warming System

Blood and Plasma Warming Device Correction: 3M Company ...

DailyTrend Sep 24, 2025  0  0